Radiation therapy

Radiotherapy basics for family physicians. Potent tool for symptom relief.
[16353832] Can Fam Physician 51(-): 1496-501 (2005)

Radiotherapy with heavy ions: radiobiology, clinical indications and experience at GSI, Darmstadt.
[9620245] Tumori 84(2): 200-4 (1998)

Hadrontherapy in the world and the programmes of the TERA Foundation.
[9620244] Tumori 84(2): 188-99 (1998)

New techniques in irradiation: clinical implications of perioperative high-dose rate brachytherapy.
[15958480] Ann Oncol 16 Suppl 2(-): ii73-8 (2005)

Radiotherapy for brain tumors.
[8124609] CA Cancer J Clin 44(2): 96-108 (1994)

A review of hypofractionated palliative radiotherapy.
[17330854] Cancer 109(8): 1462-70 (2007)

Current status of radiotherapy with proton and light ion beams.
[17326046] Cancer 109(7): 1227-38 (2007)

The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.
[16080176] Cancer 104(6): 1129-37 (2005)

Molecular targets for radiation therapy: bringing preclinical data into clinical trials.
[14506136] Clin Cancer Res 9(10 Pt 1): 3518-20 (2003)

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
[12796357] Clin Cancer Res 9(6): 1957-71 (2003)

Quarks, leptons, fermions, and bosons--the subatomic world of radiation therapy.
[16401714] Oncologist 11(1): 62-4 (2006)

Induction of cell death by radiotherapy.
[10732785] Endocr Relat Cancer 6(1): 41-4 (1999)

Radiosurgery--LINAC or gamma knife: 20 years of controversy revisited.
[16190483] Isr Med Assoc J 7(9): 583-8 (2005)

Current status of tumor radiogenic therapy.
[15918182] World J Gastroenterol 11(20): 3014-9 (2005)

HCPBM [Heavy Charged Particles in Biology & Medicine] and ENLIGHT [European Network for Light Ions] meetings, Oropa (Italy), June 2005.
[16585718] Br J Radiol 79(940): 278-84 (2006)

The case for particle therapy.
[16421401] Br J Radiol 79(937): 24-31 (2006)

Clinical use of intensity-modulated radiotherapy: part II.
[15020357] Br J Radiol 77(915): 177-82 (2004)

Clinical use of intensity-modulated radiotherapy: part I.
[15010378] Br J Radiol 77(914): 88-96 (2004)

Intensity-modulated radiotherapy (IMRT): the most important advance in radiotherapy since the linear accelerator?
[14512325] Br J Radiol 76(910): 673 (2003)

Proton beam radiotherapy.
[11026853] Br J Radiol 73(872): 802-5 (2000)

Intensity modulated radiation therapy: a clinical review.
[10884741] Br J Radiol 73(869): 459-69 (2000)

1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
[409189] AJR Am J Roentgenol 129(3): 383-93 (1977)

Radionuclide cancer therapy.
[9637275] Ann Nucl Med 12(2): 61-70 (1998)

Has the time come for doing away with Cobalt-60 teletherapy for cancer treatments.
[20098538] J Med Phys 34(2): 63-5 (2009)

Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
[16455623] J Nucl Med 47(2): 196-9 (2006)

The promise of targeted {alpha}-particle therapy.
[15653670] J Nucl Med 46 Suppl 1(-): 199S-204S (2005)

Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides.
[15653669] J Nucl Med 46 Suppl 1(-): 191S-8S (2005)

Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
[14736840] J Nucl Med 45 Suppl 1(-): 96S-101S (2004)

Emerging roles for radiometabolic therapy of tumors based on auger electron emission.
[10994732] J Nucl Med 41(9): 1519-21 (2000)

Beta irradiation: new uses for an old treatment: a review.
[12640408] Eye (Lond) 17(2): 207-15 (2003)

Synergistic cell-killing effect of a combination of hyperthermia and heavy ion beam irradiation: in expectation of a breakthrough in the treatment of refractory cancers (review).
[11744989] Int J Mol Med 9(1): 11-8 (2002)

Laser-driven proton oncology--a unique new cancer therapy?
[17768168] Br J Radiol 80(959): 855-8 (2007)

Is tomotherapy the future of IMRT?
[15107318] Br J Radiol 77(916): 285-95 (2004)

IMRT: delivery techniques and quality assurance.
[14623777] Br J Radiol 76(911): 766-76 (2003)

The physical basis of IMRT and inverse planning.
[14512327] Br J Radiol 76(910): 678-89 (2003)

Radiotherapy for benign diseases.
[10884722] Br J Radiol 73(866): 121-2 (2000)

The clinical radiobiology of brachytherapy.
[9691890] Br J Radiol 71(845): 465-83 (1998)

Tomotherapy for neurofibromatosis Type 2: case report and review of the literature.
[20335436] Br J Radiol 83(988): e74-8 (2010)

The role of autophagy in sensitizing malignant glioma cells to radiation therapy.
[19430698] Acta Biochim Biophys Sin (Shanghai) 41(5): 341-51 (2009)

Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.
[21984970] Am J Cancer Res 1(4): 521-30 (2011)

Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
[18059157] Cancer Biol Ther 6(8): 1165-70 (2007)

Radiation to control transgene expression in tumors.
[17611403] Cancer Biol Ther 6(7): 1005-12 (2007)

Modulating the tumor microenvironment to increase radiation responsiveness.
[19823031] Cancer Biol Ther 8(21): 1994-2001 (2009)

Identification and management of persistently active brachytherapy seed implants.
[19843718] AJR Am J Roentgenol 193(5): W403-6 (2009)

Radiation risk from pediatric cardiac catheterization: friendly fire on children with congenital heart disease.
[19858410] Circulation 120(19): 1847-9 (2009)

Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
[20811605] J Biomed Biotechnol 2010(-): - (2010)

Immunological aspects of local radiotherapy: clinical relevance.
[20193637] Discov Med 9(45): 119-24 (2010)

Impact of tumor hypoxia and anemia on radiation therapy outcomes.
[12490737] Oncologist 7(6): 492-508 (2002)

Radioprotectors and mitigators of radiation-induced normal tissue injury.
[20413641] Oncologist 15(4): 360-71 (2010)

Recent advances in combined modality therapy.
[20413642] Oncologist 15(4): 372-81 (2010)

Overcoming radiation resistance in inflammatory breast cancer.
[20503417] Cancer 116(11 Suppl): 2840-5 (2010)

Intensity-modulated radiation therapy: emerging cancer treatment technology.
[15856036] Br J Cancer 92(10): 1819-24 (2005)

Boron neutron capture therapy in cancer: past, present and future.
[17891250] Arq Bras Endocrinol Metabol 51(5): 852-6 (2007)

Radiotherapy and radiosurgery for Cushing's disease.
[18209876] Arq Bras Endocrinol Metabol 51(8): 1373-80 (2007)

Image-guided radiotherapy: a new dimension in radiation oncology.
[21603562] Dtsch Arztebl Int 108(16): 274-80 (2011)

Magnetic resonance imaging in assessment of treatment response of gamma knife for brain tumors.
[21740852] Chin Med J (Engl) 124(12): 1906-10 (2011)

Irradiation of human tumor tissue cultures: optimizing ion radiation therapy.
[21463137] Future Oncol 7(4): 489-91 (2011)

Are cancer stem cells radioresistant?
[21062156] Future Oncol 6(10): 1563-76 (2010)

Predicting response to clinical radiotherapy: past, present, and future directions.
[18376382] Cancer Control 15(2): 151-6 (2008)

The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.
[18376381] Cancer Control 15(2): 140-50 (2008)

Functional lung imaging in thoracic cancer radiotherapy.
[18376378] Cancer Control 15(2): 112-9 (2008)

Stereotactic body radiation therapy: transcending the conventional to improve outcomes.
[18376377] Cancer Control 15(2): 104-11 (2008)

Radioimmunotherapy with alpha-particle emitting radionuclides.
[15640792] Q J Nucl Med Mol Imaging 48(4): 289-96 (2004)

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.
[20554737] J Nucl Med 51(7): 1049-58 (2010)

Novel radiotherapy schedules aid recovery of normal tissues after treatment.
[20361066] J Gastrointestin Liver Dis 19(1): 7-8 (2010)

MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
[18376144] Cancer Biol Ther 7(6): 917-33 (2008)

Potential use of MDA-7 as a biological adjuvant for radiation therapy.
[15326389] Cancer Biol Ther 3(8): 752-4 (2004)

MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
[15197348] Cancer Biol Ther 3(8): 739-51 (2004)

mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
[14508103] Cancer Biol Ther 2(4): 347-53 (2003)

Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
[20523363] Cancer Gene Ther 17(9): 664-74 (2010)

Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer.
[16646087] J Cell Physiol 208(2): 298-306 (2006)

Induction of cytokine gene expression in human thyroid epithelial cells irradiated with HZE particles (iron ions).
[19772464] Radiat Res 172(4): 437-43 (2009)

Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
[15194048] Mol Ther 9(6): 818-28 (2004)

Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cells.
[15273727] Oncogene 23(42): 7125-31 (2004)

Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
[12606943] Oncogene 22(8): 1164-80 (2003)

NF-kappa B-mediated adaptive resistance to ionizing radiation.
[17967430] Free Radic Biol Med 44(1): 1-13 (2008)

Targeting inflammatory pathways for tumor radiosensitization.
[20599771] Biochem Pharmacol 80(12): 1904-14 (2010)

Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source.
[21358074] J Cancer Res Ther 6(4): 421-6 (2010)

Shielding in whole brain irradiation in the multileaf collimator era: dosimetric evaluation of coverage using SFOP guidelines against in-house guidelines.
[20622361] J Cancer Res Ther 6(2): 152-8 (2010)

Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
[20009291] J Cancer Res Ther 5 Suppl 1(-): S32-5 (2009)

Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors.
[20009292] J Cancer Res Ther 5 Suppl 1(-): S36-40 (2009)

Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
[20009290] J Cancer Res Ther 5 Suppl 1(-): S27-31 (2009)

Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
[20009289] J Cancer Res Ther 5 Suppl 1(-): S21-6 (2009)

Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.
[20009287] J Cancer Res Ther 5 Suppl 1(-): S16-20 (2009)

Prophylactic feeding tubes for patients with locally advanced head-and-neck cancer undergoing combined chemotherapy and radiotherapy-systematic review and recommendations for clinical practice.
[21874110] Curr Oncol 18(4): e191-201 (2011)

PET/CT-guided radiation therapy planning: from present to the future.
[20448373] Indian J Cancer 47(2): 126-33 (2010)

Radiation-induced bystander signalling in cancer therapy.
[19377507] Nat Rev Cancer 9(5): 351-60 (2009)

Development of investigational radiation modifiers.
[12734315] J Natl Cancer Inst 95(9): 646-51 (2003)

Clinically relevant standards for intensity-modulated radiation therapy dose prescription.
[18314470] J Natl Cancer Inst 100(5): 288-90 (2008)

Proton therapy in clinical practice.
[21527064] Chin J Cancer 30(5): 315-26 (2011)

Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.
[21512653] World J Radiol 3(3): 66-9 (2011)

Proton therapy dosimetry using positron emission tomography.
[21160579] World J Radiol 2(4): 135-42 (2010)

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
[21484384] Eur J Nucl Med Mol Imaging 38 Suppl 1(-): S41-7 (2011)

90Y/177Lu-DOTATATE therapy: survival of the fittest?
[21755369] Eur J Nucl Med Mol Imaging 38(10): 1785-7 (2011)

The options for the future production of the medical isotope 99Mo.
[20544192] Eur J Nucl Med Mol Imaging 37(10): 1817-20 (2010)

The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.
[17040092] Sarcoma 2006(1): 87367 (2006)

Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.
[16985930] Rev Urol 6 Suppl 10(-): S3-S12 (2004)

Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.
[21651775] Radiat Oncol 6(-): 63 (2011)

Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial.
[20964826] BMC Cancer 10(-): 572 (2010)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas.
[17760992] BMC Cancer 7(-): 167 (2007)

Extracorporeal irradiated tumor bone: A reconstruction option in diaphyseal Ewing's sarcomas.
[20924479] Indian J Orthop 44(4): 390-6 (2010)

Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.
[19959028] Semin Radiat Oncol 20(1): 21-9 (2010)

New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells.
[19835868] Eur J Pharmacol 625(1-3): 151-5 (2009)

Helical tomotherapy: a fascinating technological concept that has matured into clinical reality.
[19044319] Technol Cancer Res Treat 7(6): 415-6 (2008)

Radiation therapy: state of the art and the future.
[20299738] J Med Invest 57(1-2): 1-11 (2010)

Three endpoints of in vivo tumour radiobiology and their statistical estimation.
[20148701] Int J Radiat Biol 86(2): 164-73 (2010)

Imaging for assessment of radiation-induced normal tissue effects.
[20171509] Int J Radiat Oncol Biol Phys 76(3 Suppl): S140-4 (2010)

Hybrid computational phantoms for medical dose reconstruction.
[20039051] Radiat Environ Biophys 49(2): 155-68 (2010)

The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
[19960231] J Neurooncol 96(1): 17-32 (2010)

How can we overcome tumor hypoxia in radiation therapy?
[21952313] J Radiat Res (Tokyo) 52(5): 545-56 (2011)

Current advancement in radiation therapy for uterine cervical cancer.
[20173313] J Radiat Res (Tokyo) 51(1): 1-8 (2010)

Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS).
[20508375] J Radiat Res (Tokyo) 51(4): 355-64 (2010)

Recent innovations in carbon-ion radiotherapy.
[20679740] J Radiat Res (Tokyo) 51(4): 385-92 (2010)

Microbeam studies of the bystander response.
[19346680] J Radiat Res (Tokyo) 50 Suppl A(-): A1-6 (2009)

High LET heavy ion radiation induces p53-independent apoptosis.
[18957831] J Radiat Res (Tokyo) 50(1): 37-42 (2009)

Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.
[20135685] Stem Cells 28(4): 639-48 (2010)

Radiation responses of cancer stem cells.
[19623582] J Cell Biochem 108(2): 339-42 (2009)

Hypoxia and radiation therapy: past history, ongoing research, and future promise.
[19519402] Curr Mol Med 9(4): 442-58 (2009)

Patient positioning in the proton radiotherapy era.
[20465816] J Exp Clin Cancer Res 29(-): 47 (2010)

Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.
[21076193] Phys Med Biol 55(23): 7009-23 (2010)

The tumor-immune microenvironment and response to radiation therapy.
[21161342] J Mammary Gland Biol Neoplasia 15(4): 411-21 (2010)

CyberKnife stereotactic ablative radiotherapy for lung tumors.
[21070081] Technol Cancer Res Treat 9(6): 589-96 (2010)

CyberKnife(R) robotic stereotactic radiosurgery and stereotactic body radiation therapy.
[21070075] Technol Cancer Res Treat 9(6): 539-40 (2010)

Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.
[24688775] J Thorac Dis 6(4):303-18 (2014)

Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
[24688774] J Thorac Dis 6(4):287-302 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Radiation therapy.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Radiation therapy.php on line 92